3-NITRO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE HCL, 95.0%, 1g

4-(Trifluoromethyl)pyridazin-3(2H)-one, 98%, 1g

2-nitroterephthalaldehyde, 1g

3-(4-fluorophenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid, 95.0%, 250mg

Recipiente de laboratorio de seguridad sin pulir, con tapón de rosca y homologación UN-X, 1 l, 01T, 1 Pieza

tert-butyl 3,9-diazaspiro[5.6]dodecane-3-carboxylate, 95.0%, 5g

3-[(4-bromophenyl)methyl]-5-chloro-1,2,4-thiadiazole, 95.0%, 2g

1,1-Dioxo-1H-1lambda*6*-benzo[d]isothiazol-3-ylamine, 95.0%, 5g

3-Amino-4-iodobenzoic acid, 95.0%, 25g

4-ETHYL-2,3-DIOXOPIPERAZINE-1-CARBONYL CHLORIDE, 95.0%, 5g

2,5-di([1,1'-Biphenyl]-4-yl)-1,3,4-oxadiazole, 98%, 10g

4,4-Dimethylpent-2-ynoic acid, 97%, 1g

2-AMINO-5-FLUORO-4-METHOXYBENZOIC ACID, 95%, 1g